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Abstract
Microvascular sequestration of Plasmodium falciparum underlies cerebral malaria. Despite suggestive ex vivo
evidence, this phenomenon has not been convincingly demonstrated in coma complicating Plasmodium vivax
malaria. Severely-ill Papua New Guinean children with mixed P. falciparum/P. vivax infections are more likely to
develop cerebral malaria and die than those with P. falciparum alone, possibly reflecting P. vivax sequestration.
Nested PCR was performed on post mortem brain tissue from three such children dying from cerebral malaria due
to mixed-species infections. No P. vivax DNA was detected. These findings do not support the hypothesis that P.
vivax sequestration occurs in human brain.
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Background
Plasmodium vivax accounts for nearly half of all malaria
infections and is now recognized as a cause of complica-
tions and death [1]. Cerebral malaria due to P. vivax,
although rare, has been reported from Indonesia, India
and Papua New Guinea (PNG) [2-4]. In patients with
altered consciousness due to Plasmodium falciparum,
late stage parasites (trophozoites and schizonts) can be
found sequestered within the brain microvasculature.
There is no convincing evidence of a similar phenom-
enon in post mortem brain specimens from patients
with P. vivax, but available data are few and from stu-
dies in which interpretation of the histopathologic fea-
tures is confounded by issues such as the possibility of
unrecognized mixed-species infections [5].
Animal and in vivo functional studies reveal that
P. vivax sequesters preferentially in the pulmonary and
splenic microvasculature [5], consistent with clinical stu-
dies in which pulmonary manifestations and severe
anaemia occur relatively frequently [2,6]. Ex vivo studies
have shown cytoadherence of P. vivax to chondroitin
sulphate A, erythrocyte rosetting and endothelial adher-
ence [5,7,8], albeit at lower avidity than P. falciparum.
Nevertheless, these observations raise the possibility that
cerebral microvascular sequestration may underlie cere-
bral malaria due to P. vivax.
Apart from research settings [9], autopsy studies of
patients dying from malaria are rarely performed. In the
case of fatal cerebral vivax malaria, there have been no
published post mortem studies for > 60 years [5]. The
results of a prospective observational study of severely ill
PNG children with malaria were reported recently [2].
Those with mixed P. falciparum/P. vivax infections were
more likely to have impaired consciousness and to die
than those infected with P. falciparum alone. In the pre-
sent study, histopathologic and molecular studies were
performed using brain tissue from three of the fatal cases
in this series [2] in order to examine the hypothesis that
cerebral sequestration of P. vivax contributed to their
presenting neurological features and outcome.
Details of the main prospective observational study
from which the present cases are drawn have been pub-
lished [2]. In brief, all children aged 0.5-10 years admitted
to Modilon Hospital, Madang Province, between October
2006 and December 2009 were assessed for recruitment
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Inclusion criteria reflected the World Health Organiza-
tion (WHO) definition of severe malarial illness. All chil-
dren were screened for malaria by both blood film
microscopy and subsequent diagnostic and Plasmodium
species confirmation by nested polymerase chain reaction
(nPCR) [10]. In-patient management was co-ordinated by
attending ward clinicians under PNG national guidelines.
Cerebral malaria was defined as a Blantyre Coma
Score ≤2w i t hPlasmodium DNA detected in peripheral
blood by nPCR [2], irrespective of the presence and/or
species of asexual parasites by microscopy. A mixed
P. falciparum/P. vivax infection was defined as the pre-
sence of both species DNA by nPCR, regardless of spe-
cies or parasitaemia detected microscopically. Post
mortem brain tissue was obtained using a bone marrow
biopsy needle via a supra-orbital approach [9]. Small
fragments of brain tissue were placed between two
slides, gently squashed, stained with 2.5% Giemsa for
one hour before microscopic examination. Additional
pieces of brain tissue were stored in formalin and liquid
nitrogen. Formalin-fixed tissue was embedded in paraf-
fin, sectioned and stained with haematoxylin and eosin
(H&E), Gram’s, Giemsa and silver stain prior to micro-
scopy which was performed by a specialist neuropathol-
ogist (CM) in a pathology laboratory accredited by the
Australian National Association of Testing Authorities.
Initial Plasmodium species identification was performed
on peripheral blood by nPCR [10] after parasite DNA
extraction (QIAamp 96 DNA Blood Mini Kit, QIAGEN,
Valencia, CA). Positive samples for mixed P. falciparum/
P. vivax infection were quantified by PCR (qPCR) using
validated methods [11]. Brain tissue stored in liquid nitro-
gen or formalin was homogenized before DNA extraction
( D N e a s yB l o o d&T i s s u eK i t ,Q I A G E N ,V a l e n c i a ,C A ,
USA) prior to nPCR.
Case presentations
Three children of 340 with severe malaria died from cer-
ebral malaria and underwent post mortem brain biopsy.
No brain biopsy material was available for the other three
children in the series as a whole who died. All three of
the present children had a mixed P. falciparum/P. vivax
infection detected from peripheral blood by nPCR. Their
admission clinical and laboratory features are summar-
ized in Table 1.
Case 1
This child presented in deep coma without other features
of severe malaria and died within hours of admission
despite prompt anti-malarial therapy and supportive
treatment. P. falciparum was present on blood smear and
nPCR, but P. vivax was not identified by microscopy and
only at low levels (> 40 cycles) by qPCR. The qPCR data
represent a P. falciparum and P. vivax parasitaemia of
10,000 and < 10 parasites/μL, respectively [11]. Micro-
scopy of brain tissue revealed occasional P. falciparum
parasites and no identifiable P. vivax within the cerebral
vasculature (Figure 1). No inflammation, haemorrhage or
necrosis was observed in the adjacent brain parenchyma.
Plasmodium falciparum but not P. vivax was present in
brain by nPCR.
Case 2
This patient presented with cerebral malaria, metabolic
acidosis, hyperlactataemia and severe anaemia. This child
died within hours of admission despite prompt anti-malar-
ial therapy and supportive treatment. P. falciparum and
P. vivax in peripheral blood were identified by microscopy,
nPCR and qPCR. Using qPCR, P. falciparum and P. vivax
DNA concentrations indicated equivalent parasitaemia of
50,000 and 500/μL, respectively. Plasmodium falciparum,
but not P. vivax, was present in brain by nPCR. Malaria
pigment and numerous P. falciparum trophozoites and
schizonts were visible within the microvasculature on his-
tologic examination (Figure 1). Other than subtle focal up-
regulation of microglial cells, there were no abnormalities
observed in the adjacent brain parenchyma.
Case 3
This child presented deeply comatose. Seven days before
admission, he attended a local clinic with headache and
fever and was prescribed amodiaquine, sulphadoxine and
pyrimethamine. He did not improve and was given intra-
muscular artemether five days later. On admission to
Modilon Hospital, blood film microscopy and a rapid diag-
nostic test for malaria were negative, but both species were
subsequently detected by nPCR of peripheral blood and at
low levels by qPCR (10-100 parasites/μL). At lumbar
puncture, there were 5 leucocytes/μL (100% lymphocytes)
in the cerebrospinal fluid (CSF) and the CSF protein con-
centration was 3 g/L. Blood cultures were negative. He did
not regain consciousness and died four days later despite
intravenous dextrose/saline and antibiotics, and intramus-
cular artemether.
Neither P. falciparum nor P. vivax was present in the
brain of Patient 3 by nPCR. Further molecular testing of
CSF and brain tissue for arbo-, Henipah, Entero- and
Herpes viruses did not reveal an alternative diagnosis. His-
topathologic examination of brain tissue showed infarction
of cortical tissue with acute chromatolysis of neurons and
early infiltration by neutrophils from adjacent vessels at
the edge of the infarction (Figure 1). Adjacent white mat-
ter was unaffected and cerebral vessels appeared normal.
No lymphocytes, histiocytes, granulomata, malarial para-
sites, fungal hyphae, bacteria or emboli were seen. The
changes were interpreted as cortical infarction of at least
24 hours duration without a definitive aetiology.
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The present case series provides the first detailed histo-
pathologic and molecular study of the potential role of P.
vivax i nt h ep a t h o g e n e s i so fc o m aa sam a n i f e s t a t i o no f
severe malaria. There was no evidence for cerebral
sequestration of P. vivax in any of the three cases despite
microscopic and/or molecular confirmation that this
parasite was present in peripheral blood at presentation.
Thus, despite ex vivo studies suggesting that cytoadher-
ence of P. vivax might contribute to complications
[5,7,8], the present data do not support the hypothesis
that this phenomenon occurs in the human brain.
Patient 1 was diagnosed and treated as a case of cerebral
malaria due to a P. falciparum mono-infection. By impli-
cation from the peripheral blood microscopy and qPCR
data, this young girl’st o t a lP. vivax parasite burden was
relatively low and the negative cerebral histopathology and
nPCR could have reflected this. Mature P. falciparum
forms in the brain in this patient were scarce compared to
the peripheral parasitaemia (154,000/μL). This suggests
that she had a synchronous infection with either maturing
parasite forms starting to cytoadhere, or (less likely in view
of the lack of intravascular malaria pigment) maturation
and rupture of schizonts just before presentation. Whether
a similar phenomenon might operate in the case of
P. vivax is unknown. In a typical patient with P. falci-
parum, about half of the infected erythrocytes are seques-
tered [12]. It is possible that the dynamics of putative
P. vivax sequestration with less avid ligand binding [7] are
different to P. falciparum in that the majority of parasites
remain in the peripheral blood. This could explain the
weakly positive PCR in blood and negative PCR in the
brain of this patient if P. vivax cytoadherence were
possible.
Patient 2 provides the strongest evidence against
P. vivax cerebral cytoadherence. This child had a mixed-
species infection identifiable by peripheral blood micro-
scopy but nPCR of brain tissue was only positive for
P. falciparum. The difference in peripheral blood P. vivax
density observed by qPCR compared to microscopy (500
vs 80/μL, respectively) is likely to reflect the fact that even
very experienced microscopists often overlook a second
infecting species in mixed infections [13]. Brain histology
in this patient showed an abundance of P. falciparum and
its greater avidity for endothelial ligands under both static
and flow conditions [7] may have competitively inhibited
P. vivax cytoadherence. However, the distribution of P. fal-
ciparum sequestration varies significantly between cerebral
vessels in the same patient [14] and, in any case, the
absence of P. vivax by nPCR implies that this parasite had
no direct role in causing deep coma.
Patient 3 was included in the present series because of
the positive peripheral blood PCR results. In studies of
P. falciparum, mature parasite forms are no longer visible
in brain biopsy specimens three days after anti-malarial
treatment [14] and this patient died seven days after intra-
muscular artemether. It is, therefore, not surprising that
brain nPCR was negative for P. falciparum and, even if
cerebral P. vivax sequestration had contributed to coma,
that brain nPCR was also negative for P. vivax.I s c h e m i a
and infarction can occur in cerebral malaria caused by
P. falciparum in children [15]. It is likely that histologic
appearances in this patient, coupled with prior anti-malar-
ial treatment, low-grade parasitaemia detected by PCR and
Table 1 Clinical and laboratory features of children dying from cerebral malaria due to mixed Plasmodium falciparum/
Plasmodium vivax infections
Patient 1 Patient 2 Patient 3
Age (months) 63 36 94
Sex Female Female Male
Blantyre coma score on admission 0 2 1
Blood lactate (mmol/L) 1.6 6.4 1.0
Plasma bicarbonate (mmol/L) 18 10.2 22.3
Blood glucose (mmol/L) 18.4 3.2 7.0
Haemoglobin (g/L) 69 39 111
Peripheral parasitaemia (/μL) by light microscopy:
P. falciparum 154,000 104,000 0
P. vivax 08 0 0
Plasmodium species by nPCR (blood) Mixed species Mixed species Mixed species
Peripheral parasitaemia by qPCR (number of cycles):
P. falciparum 26.3 23.1 37.2
P. vivax 41.0 29.2 35.8
Plasmodium species by nPCR (brain) P. falciparum P. falciparum Negative
nPCR, nested polymerase chain reaction [10]; qPCR, quantitative polymerase chain reaction [11]
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the adverse and persistent neurologic effects of substantial
P. falciparum sequestration prior to admission. The role
of P. vivax in this process remains speculative.
There were no cases of P. vivax mono-infections in the
present post mortem series. Children with pure severe
vivax malaria in the main study had a significantly
greater parasitaemia than those of P. vivax in the mixed
infection group [2], but none of these 27 children died of
cerebral malaria and only one (3.7%) presented in deep
coma (Blantyre Coma Score ≤ 2; vs 10.3% for P. falci-
parum mono-infections and 22.0% for mixed species
infections [2]). This is further indirect evidence against
cerebral sequestration due to P. vivax.
T h el o wm o r t a l i t yr a t ei nt h em a i ns t u d y[ 2 ]a n dc u l -
tural difficulties in obtaining post mortem samples in
PNG meant that there was limited availability of brain
tissue. Nevertheless, detailed phenotypic, laboratory and
outcome data were available for each of the three chil-
dren. In addition, Plasmodium DNA was successfully
extracted from brain tissue, implying that the absence of
P. vivax DNA was not due to laboratory factors.
The present results suggest that P. vivax cytoadher-
ence in brain is not a significant pathophysiologic
mechanism underlying impaired consciousness in
severely ill children with mixed species malaria. Other
factors that underlie the poor prognosis of mixed spe-
cies infections in the present series include the possibi-
lity that enhanced cytokine and/or toxin production
associated with P. vivax [5] amplifies the effects of P.
falciparum s e q u e s t r a t i o no nv i t a lo r g a nf u n c t i o n ,a n d
even that the presence of P. vivax in peripheral blood
facilitates cytoadhesion of P. falciparum. The global bur-
den of vivax malaria and the increasing recognition that
this parasite can have adverse effects on the human
host, especially in concert with P. falciparum, make this
an important area for further study.
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Figure 1 Light microscopy of brain tissue obtained from
children dying from cerebral malaria due to mixed
Plasmodium falciparum/Plasmodium vivax infections. In panel A
(Patient 1), occasional mature forms of P. falciparum were seen
(Giemsa, magnification × 400). In panel B (Patient 2), malaria
pigment and numerous P. falciparum trophozoites and schizonts are
visible within the microvasculature (Giemsa, magnification x400). In
panel C (Patient 3), there is acute chromatolysis of neurons and
early infiltration by neutrophils from adjacent vessels at the edge of
an area of infarction. The cerebral blood vessel (lower left) was
normal and no malaria parasites were seen (H&E, magnification ×
400).
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